ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA)
CUSIP: 29273B302
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,186,300
- Total 13F shares
- 139,748
- Share change
- +139,748
- Total reported value
- $568,234
- Price per share
- $4.07
- Number of holders
- 11
- Value change
- +$568,234
- Number of buys
- 11
Quarterly Holders Quick Answers
What is CUSIP 29273B302?
CUSIP 29273B302 identifies NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q1 2023
Recent filing periods for CUSIP 29273B302:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
996,822
|
$305,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
864,573
|
$265,000 | — | 30 Sep 2022 | |
| NewEdge Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
656,111
|
$201,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
344,992
|
$105,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
282,473
|
$86,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
105,691
|
$32,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
90,287
|
$28,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
75,957
|
$23,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
63,378
|
$19,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
25,635
|
$8,000 | — | 30 Sep 2022 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
—
class O/S missing
|
17,111
|
$5,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
—
class O/S missing
|
15,310
|
$5,000 | — | 30 Sep 2022 | |
| Worth Asset Management, LLC |
13F
|
Company |
—
class O/S missing
|
4,200
|
$1,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
2,057
|
$1,000 | — | 30 Sep 2022 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
—
class O/S missing
|
2,000
|
$1,000 | — | 30 Sep 2022 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 |
Institutional Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q4 2022
As of 31 Dec 2022,
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
139,748 shares.
The largest 10 holders included
VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, ADVISOR GROUP HOLDINGS, INC., JPMORGAN CHASE & CO, UBS Group AG, Royal Bank of Canada, BlackRock Inc., and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q2 2024 Across Filers
Q2 2024 holders
16
Q4 2022 holders
11
Holder diff
-5
| Investor | Q2 2024 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.